La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Evolus Dividende
Dividende contrôle des critères 0/6
Evolus does not have a record of paying a dividend.
Informations clés
n/a
Rendement du dividende
n/a
Ratio de distribution
Rendement moyen de l'industrie | 2.2% |
Prochaine date de paiement du dividende | n/a |
Date ex-dividende | n/a |
Dividende par action | n/a |
Résultat par action | -US$0.84 |
Prévisions de rendement du dividende à 3 ans | n/a |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Evolus Continues To Make Progress
Aug 02Evolus, Inc. (NASDAQ:EOLS) Looks Just Right With A 32% Price Jump
Aug 02Evolus (NASDAQ:EOLS) Is Making Moderate Use Of Debt
Jul 13Evolus: Chiseling Away At The Aesthetic Market
May 22Analysts Are Updating Their Evolus, Inc. (NASDAQ:EOLS) Estimates After Its First-Quarter Results
May 10Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028
Mar 20The Evolus, Inc. (NASDAQ:EOLS) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 10Evolus, Inc. (NASDAQ:EOLS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Jan 18Evolus, Inc.'s (NASDAQ:EOLS) Shares Climb 27% But Its Business Is Yet to Catch Up
Jan 18Would Evolus (NASDAQ:EOLS) Be Better Off With Less Debt?
Jun 16Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?
Nov 06Evolus concludes certain royalty payments related to settlement of IP rights dispute
Sep 21Evolus: Turning That Frown Upside Down
Sep 11Evolus appoints Experian's exec as CFO
Aug 30Is Evolus (NASDAQ:EOLS) Using Too Much Debt?
Aug 04Evolus Q2 2022 Earnings Preview
Aug 01Is Evolus (NASDAQ:EOLS) Using Debt Sensibly?
Mar 21Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Insufficient data to determine if EOLS's dividends per share have been stable in the past.
Dividende croissant: Insufficient data to determine if EOLS's dividend payments have been increasing.
Rendement des dividendes par rapport au marché
Evolus Rendement des dividendes par rapport au marché |
---|
Segment | Rendement du dividende |
---|---|
Entreprise (EOLS) | n/a |
25% du marché (US) | 1.5% |
25% du marché (US) | 4.4% |
Moyenne du secteur (Pharmaceuticals) | 2.2% |
Prévisions des analystes dans 3 ans (EOLS) | n/a |
Dividende notable: Impossible d'évaluer le rendement des dividendes de EOLS par rapport aux 25 % les moins bien payés par les actionnaires, car la société n'a signalé aucun versement récent.
Dividende élevé: Unable to evaluate EOLS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Bénéfice distribué aux actionnaires
Couverture des revenus: Insufficient data to calculate EOLS's payout ratio to determine if its dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as EOLS has not reported any payouts.